Gabelli Funds’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Gabelli Funds’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-118,155	Closed	-$7.09M	–	1481
2021 Q1	$7.09M	Buy	+118,155	New	+$4.28M	0.05%	422

Gabelli Funds's PAND Position: Q2 2021 in Review

Gabelli Funds sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 118,155 shares — an estimated $7.09M sold.

Gabelli Funds first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $7.09M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Gabelli Funds reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Gabelli Funds sold 118,155 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $7.09M.
Gabelli Funds first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Gabelli Funds's Pandion Therapeutics Inc. Common Stock position peaked at $7.09M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Gabelli Funds's 13F filing for Q2 2021, filed 13 Aug 2021.